Lithuania — Vitamins, Minerals, Proteins, and Unconventional Dietary Specialties for Humans

← back to leaderboard

Lithuania received 2 FDA import refusals in Vitamins, Minerals, Proteins, and Unconventional Dietary Specialties for Humans between 2023-Q4 and 2026-Q3. Volume is newly active in the last year. The most-cited issues are dietarylbl, nutrit lbl, and lacks firm. No trade baseline is published for this commodity from Lithuania, so no per-$1B rate is shown here.

Of these, 1 were hazard refusals and 1 were paperwork refusals.

Exporting from Lithuania? Get an email when shipments from Lithuania are refused at the US border — before your buyers ask.

Quarterly rejections, last 12 quarters

0 2023-Q4 2023-Q4: 0 0 2024-Q1 2024-Q1: 0 0 2024-Q2 2024-Q2: 0 0 2024-Q3 2024-Q3: 0 0 2024-Q4 2024-Q4: 0 0 2025-Q1 2025-Q1: 0 0 2025-Q2 2025-Q2: 0 0 2025-Q3 2025-Q3: 0 0 2025-Q4 2025-Q4: 0 0 2026-Q1 2026-Q1: 0 0 2026-Q2 2026-Q2: 0 2 2026-Q3 2026-Q3: 2

By commodity, last 156 weeks

Commodity Rejections Per $1B US imports Most-cited hazard
Herbals-Botanicals 1 lacks firm
Supplements 1 nutrit lbl

Recent rejections